https://www.selleckchem.com/products/sb-3ct.html
22; P= 0.0032), and revision LSF (12.8%; P= 0.0004 vs. 9.9%; OR, 1.41; P 0.0001; hazard ratio, 1.69; P 0.0001). Patients who underwent LSF after a remote history of THA had no significant difference in DVT (4.2% vs. 2.6%, aOR, 1.31; P= 0.219, neurologic complications (1.0% vs. 0.5%, aOR, 2.02; P= 0.122, revision surgery (9.6% vs. 9.9%, aOR, 1.06; P= 0.7197), or prolonged opioid use (36.5% vs. 24.4%, aOR, 1.17; P= 0.112. Patients who undergo LSF with a history of THA may be at increased risk of postoperative complications,
Like
Comment
Share
